MAP Pharmaceuticals Wire

Results 1 - 20 of 29 in MAP Pharmaceuticals

1. MAP Pharmaceuticals shares rise in chaotic trading

   Thursday Nov 13 | International Business Times

   Shares of MAP Pharmaceuticals Inc. rose in chaotic trading Thursday as the company posted a wider-than-expected third-quarter loss while it moves two key drug candidates through late-stage development.

   Comment?

   Related Topix: Startups, Mountain View, CA, Migraine, Medicine, Health

2. MAP Pharma CEO says no need to raise capital

   Thursday Nov 13 | Reuters

   MAP Pharmaceuticals Inc has enough cash on hand to maintain operations through the release of pivotal data on its two major products, Chief Executive Tim Nelson told Reuters on Thursday.

   Comment?

   Related Topix: Startups, Migraine Headache, Medicine, Health

3. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results

   Thursday Nov 13 | Med Ad News

   MAP Pharmaceuticals, Inc. today announced financial results for the third quarter ended September 30, 2008.

   Comment?

   Related Topix: Startups, Healthcare Law, Law, Pulmicort, Budesonide (generic), Medicine, Medication, Asthma, Health, Food and Drug Administration

4. MAP Pharma Q3 loss widens to $20.4M

   Wednesday Nov 12 | San Jose Business Journal

   MAP Pharmaceuticals Inc. said Wednesday its third quarter loss was $20.4 million, widened from a loss in the same period last year of $9.8 million.

   Comment?

   Related Topix: Startups

5. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference

   Monday Nov 10 | The South Mississippi Sun Herald

   MAP Pharmaceuticals, Inc. today announced that the Company will present at the Lazard Capital Markets 5th Annual Healthcare Conference on Tuesday, November 18, 2008, at 9:55 am in New York City.

   Comment?

   Related Topix: Startups, Pulmicort, Budesonide (generic), Medicine, Medication

6. MAP Pharmaceuticals Appoints Scott R. Ward to Board of Directors

   Sep 25, 2008 | PR Newswire

   MAP Pharmaceuticals, Inc. today announced the appointment of Scott R. Ward to its Board of Directors.

   Comment?

   Related Topix: Startups, Medtronic, Medical Equipment, Healthcare Industry

7. MAP Pharmaceuticals Announces Completion Of Enrollment In Phase 3 Trial Of Unit Dose Budesonide In Children With Asthma

   Sep 23, 2008 | MediLexicon

   Main Category: Respiratory / Asthma Also Included In: Pharma Industry / Biotech Industry MAP Pharmaceuticals, Inc.

   Comment?

   Related Topix: Healthcare Law, Pulmicort, Budesonide (generic), Medicine, Law, Medication, Startups, Health

8. MAP Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference

   Sep 4, 2008 | The South Mississippi Sun Herald

   MAP Pharmaceuticals, Inc. today announced that the Company will present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008, at 10:20 am in New York City.

   Comment?

   Related Topix: Startups, Medicine, Asthma

9. MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice...

   Jul 23, 2008 | PR Newswire

   MAP Pharmaceuticals, Inc. today announced the appointment of Donald J. Kellerman, Pharm.D. to the position of Senior Vice President, Clinical Development and Medical Affairs.

   Comment?

   Related Topix: Medicine, Medication, Fluticasone (generic), Flovent, Biotech, Inspire Pharmaceuticals, Healthcare Industry, Startups, Healthcare Law, Law

10. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion

    Jul 16, 2008 | PR Newswire

    MAP Pharmaceuticals, Inc. announced that the positive results from a Phase 2 study evaluating the safety, tolerability and pharmacokinetics of MAP0004 in adult asthmatics were published in the July issue of ...

    Comment?

    Related Topix: Medical University of South Carolina, Research College of Nursing, Medical College of Wisconsin, Startups, The College of Wooster

11. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial In Patients With Migraine

    Jul 15, 2008 | Medical News Today

    ... Industry Article Date: 15 Jul 2008 - 0:00 PDT printer friendly view / write opinions rate article MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced it has initiated its Phase 3 clinical program to evaluate MAP0004 as a potential treatment for ...

    Comment?

    Related Topix: Healthcare Law, Law, Startups, The College of New Jersey, The College of Wooster, The College of Idaho, The University of Findlay

12. Map Pharmaceuticals starts migraine drug test

    Jul 14, 2008 | The San Francisco Business Times

    Map Pharmaceuticals Inc. started Phase III testing of a treatment for migraine. The Mountain View company is testing MAP0004, an inhaled drug that relieved patients' pain in as fast as 10 minutes during earlier ...

    Comment?

    Related Topix: Migraine, Medicine, Health, Startups

13. MAP Pharmaceuticals Reports Positive Pharmacological Response Data...

    Jun 29, 2008 | Medical News Today

    Main Category: Headache / Migraine Also Included In: Clinical Trials / Drug Trials ; Conferences ; Pharma Industry / Biotech Industry Article Date: 29 Jun 2008 - 0:00 PDT MAP Pharmaceuticals, Inc.

    Comment?

    Related Topix: Startups, Migraine, Medicine, Health, Nausea

14. MAP Pharma reports progress with inhaled migraine drug

    Jun 29, 2008 | Market Watch

    MAP Pharmaceuticals Inc., the Mountain View, Calif., drug developer, reported progress with MAP0004, an inhaled medication designed to treat migraines.

    Comment?

    Related Topix: Startups, Mountain View, CA, Migraine, Medicine, Health

15. MAP Pharmaceuticals Reports Positive Pharmacological Response Data...

    May 14, 2008 | Earth Times

    MOUNTAIN VIEW, Calif. , /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. today presented data from an in-vitro study evaluating receptor pharmacology of MAP0004, orally inhaled dihydroergotamine for the ...

    Comment?

    Related Topix: Mountain View, CA, Startups, Medicine, Migraine, Health, Nausea

16. MAP Pharmaceuticals, Inc. Acquires Proprietary Drug Particle...

    Jun 25, 2008 | BioSpace

    MAP Pharmaceuticals, Inc. today announced that Telesso Technologies Limited, formerly Eiffel Technologies Limited , has agreed to transfer and assign to MAP Pharmaceuticals previously licensed intellectual ...

    Comment?

    Related Topix: Startups

17. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation...

    Jun 24, 2008 | PR Newswire

    MAP Pharmaceuticals, Inc. today announced that Telesso Technologies Limited, formerly Eiffel Technologies Limited , has agreed to transfer and assign to MAP Pharmaceuticals previously licensed intellectual ...

    Comment?

    Related Topix: Startups

18. Appointments And Advancements

    Jun 20, 2008 | Customer Interaction Solutions

    MAP Pharmaceuticals Inc., of Mountain View, Calif., named Marco F. Rosa vice president of human resources.

    Comment?

    Related Topix: Startups, Mountain View, CA

19. MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference

    Apr 6, 2008 | PR Newswire

    MAP Pharmaceuticals, Inc. today announced that the Company will present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Tuesday, June 10, 2008, at 4:00 pm in Dana Point, California.

    Comment?

    Related Topix: Dana Point, CA, Startups

20. MAP Pharmaceuticals to Present at the 2008 Citi Investment Research Global Healthcare Conference

    May 16, 2008 | PR Newswire

    MAP Pharmaceuticals, Inc. today announced that the Company will present at the 2008 Citi Investment Research Global Healthcare Conference on Wednesday, May 21, 2008, at 9:00 am in New York City.

    Comment?

    Related Topix: Startups